1-Piperazinecarboxylic acid, 4-[trans-4-[[6-(cyanomethyl)-2-[(1-methyl-1H-pyrazol-4-yl)amino]pyrido[3,2-d]pyrimidin-4-yl]amino]cyclohexyl]-, methyl ester

Request For Quotation
1-Piperazinecarboxylic acid, 4-[trans-4-[[6-(cyanomethyl)-2-[(1-methyl-1H-pyrazol-4-yl)amino]pyrido[3,2-d]pyrimidin-4-yl]amino]cyclohexyl]-, methyl ester Suppliers list
Company Name: Shanghai YuanYe Biotechnology Co., Ltd.  
Tel: 15026964105
Email: 2881489226@qq.com
Company Name: RD International Technology Co., Limited  
Tel: 18024082417
Email: market@ubiochem.com
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Email: marketing@targetmol.cn
Company Name: Aladdin Scientific  
Tel:
Email: tp@aladdinsci.com
1-Piperazinecarboxylic acid, 4-[trans-4-[[6-(cyanomethyl)-2-[(1-methyl-1H-pyrazol-4-yl)amino]pyrido[3,2-d]pyrimidin-4-yl]amino]cyclohexyl]-, methyl ester Basic information
Product Name:1-Piperazinecarboxylic acid, 4-[trans-4-[[6-(cyanomethyl)-2-[(1-methyl-1H-pyrazol-4-yl)amino]pyrido[3,2-d]pyrimidin-4-yl]amino]cyclohexyl]-, methyl ester
Synonyms:1-Piperazinecarboxylic acid, 4-[trans-4-[[6-(cyanomethyl)-2-[(1-methyl-1H-pyrazol-4-yl)amino]pyrido[3,2-d]pyrimidin-4-yl]amino]cyclohexyl]-, methyl ester;IRAK4-IN-6
CAS:2454244-02-9
MF:C25H32N10O2
MW:504.59
EINECS:
Product Categories:
Mol File:2454244-02-9.mol
1-Piperazinecarboxylic acid, 4-[trans-4-[[6-(cyanomethyl)-2-[(1-methyl-1H-pyrazol-4-yl)amino]pyrido[3,2-d]pyrimidin-4-yl]amino]cyclohexyl]-, methyl ester Structure
1-Piperazinecarboxylic acid, 4-[trans-4-[[6-(cyanomethyl)-2-[(1-methyl-1H-pyrazol-4-yl)amino]pyrido[3,2-d]pyrimidin-4-yl]amino]cyclohexyl]-, methyl ester Chemical Properties
Boiling point 741.4±70.0 °C(Predicted)
density 1.43±0.1 g/cm3(Predicted)
storage temp. Store at -20°C
solubility DMSO : 125 mg/mL (247.73 mM)
pka7.18±0.70(Predicted)
form Powder
color Light yellow to yellow
Safety Information
MSDS Information
1-Piperazinecarboxylic acid, 4-[trans-4-[[6-(cyanomethyl)-2-[(1-methyl-1H-pyrazol-4-yl)amino]pyrido[3,2-d]pyrimidin-4-yl]amino]cyclohexyl]-, methyl ester Usage And Synthesis
UsesIRAK4-IN-6 is an orally efficacious and selective IRAK4 inhibitor with an IC50 of 4 nM, and targetes MyD88 L265P mutant diffuse large B cell lymphoma[1].
References[1] Degorce SL, et al. Discovery of a Series of 5-Azaquinazolines as Orally Efficacious IRAK4 Inhibitors TargetingMyD88L265P Mutant Diffuse Large B Cell Lymphoma. J Med Chem. 2019 Nov 1. DOI:10.1021/acs.jmedchem.9b01346
1-Piperazinecarboxylic acid, 4-[trans-4-[[6-(cyanomethyl)-2-[(1-methyl-1H-pyrazol-4-yl)amino]pyrido[3,2-d]pyrimidin-4-yl]amino]cyclohexyl]-, methyl ester Preparation Products And Raw materials
Tag:1-Piperazinecarboxylic acid, 4-[trans-4-[[6-(cyanomethyl)-2-[(1-methyl-1H-pyrazol-4-yl)amino]pyrido[3,2-d]pyrimidin-4-yl]amino]cyclohexyl]-, methyl ester(2454244-02-9) Related Product Information
LCC-12 (formate) FMF-06-098-1 Anti-cancer compound library IRAK4-IN-1 2-Pyridinecarboxamide, 6-(1,1-difluoroethyl)-N-[2-[trans-4-[[2-[2-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]amino]ethyl]-7-azaspiro[3.5]non-7-yl]methyl]cyclohexyl]-6-methoxy-2H-indazol-5-yl]- N-[2-[trans-4-[[6-[2-[[2-(2,6-Dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]amino]ethyl]-2-azaspiro[3.3]hept-2-yl]methyl]cyclohexyl]-5-(1-hydroxy-1-methylethyl)-6-benzothiazolyl]-6-(trifluoromethyl)-2-pyridinecarboxamide